Drug profile · INN
seladelpar lysine
LIVDELZI
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
seladelpar lysine (LIVDELZI) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN seladelpar lysine
Brand LIVDELZI
Route ORAL
Formulation CAPSULE
Frequently asked questions
What is seladelpar lysine?
seladelpar lysine (LIVDELZI) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for seladelpar lysine?
LIVDELZI is a marketed brand name for seladelpar lysine. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of seladelpar lysine?
seladelpar lysine has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.